A detailed history of Four Thought Financial, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Four Thought Financial, LLC holds 12,406 shares of CORT stock, worth $713,841. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,406
Previous 12,406 -0.0%
Holding current value
$713,841
Previous $295,000 7.8%
% of portfolio
0.05%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Nov 12, 2021

SELL
$23.49 - $30.56 $179,909 - $234,059
-7,659 Reduced 38.17%
12,406 $295,000
Q4 2020

Nov 12, 2021

BUY
$16.78 - $27.3 $336,690 - $547,774
20,065 New
20,065 $524,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.16B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.